FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 2	2025-03-05		NCT06858618

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Fosun Pharmaceutical Technology Development Co., Ltd.	1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	24

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Union hospital tongjimedical college huzhong university of science and technology	Wuhan	China	1

Clinical trials